Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 14.51
- Piotroski Score 3.00
- Grade Buy
- Symbol (KURA)
- Company Kura Oncology, Inc.
- Price $18.06
- Changes Percentage (-0.66%)
- Change -$0.12
- Day Low $18.03
- Day High $18.65
- Year High $24.17
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A protein-protein interaction for the treatment of genetically defined subsets of acute leukemias, including acute myeloid leukemia and acute lymphoblastic leukemia; and tipifarnib, an orally bioavailable inhibitor of farnesyl transferase that is in Phase II clinical trials for the treatment of solid tumors and hematologic indications. The company has a clinical collaboration with Novartis to evaluate the combination of tipifarnib and alpelisib in patients with head and neck squamous cell carcinoma whose tumors have HRAS overexpression or PIK3CA mutation and/or amplification. Kura Oncology, Inc. was founded in 2014 and is headquartered in San Diego, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 10/30/2024
- Fiscal Year End N/A
- Average Stock Price Target $28.00
- High Stock Price Target $32.00
- Low Stock Price Target $26.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$2.17
- Trailing P/E Ratio -10.03
- Forward P/E Ratio -10.03
- P/E Growth -10.03
- Net Income $-152,631,000
Income Statement
Quarterly
Annual
Latest News of KURA
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Sakura is getting a preview of the perfect place to burn off extra energy for you and your kids!
Experience the World's Biggest Bounce Park® at FUNBOX in Westfield Galleria for the next 7 weekends. Enjoy 25,000 sq ft of inflatable fun with 10 exciting play zones like Tumble Temple and Marshmallo...
By CBS News | 2 weeks ago -
Why Kura Sushi USA Was Such a Tasty Stock This Week
Kura Sushi USA's stock surged nearly 24% this week due to positive analyst coverage and news of its parent company building the world's longest conveyor belt sushi restaurant at the World Expo in Osak...
By Yahoo! Finance | 3 weeks ago -
Kura Sushi USA (KRUS) Traded Down Due to Negative Market Sentiment
Fred Alger Management released its Q2 2024 investor letter for the "Alger Small Cap Growth Fund," noting the rise in U.S. equities and large-cap growth stocks. Kura Sushi USA, Inc. was highlighted, wi...
By Yahoo! Finance | 1 month ago
